Skip to main content
OpenTrials

Clinical trial condition

CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma

Explore clinical trials studying CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma trial results

Conditions
CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
Locations
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
View all 16 locations